Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cosmax NBT Inc. (222040:KRX), powered by AI.
Cosmax NBT Inc. is currently trading at ₩6,790. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cosmax NBT Inc. on Alpha Lenz.
Cosmax NBT Inc.'s P/E ratio is -9.3.
“Cosmax NBT Inc. trades at a P/E of -9.3 (undervalued) with modest ROE of -29.6%.”
Ask for details →Cosmax NBT Inc. is a leading South Korean company specializing in the research, development, and manufacturing of natural bio materials for health supplements and nutraceuticals. The primary function of Cosmax NBT Inc. is to innovate and provide high-quality, science-based health and wellness products tailored to a broad range of needs. Its notable features include cutting-edge R&D capabilities and a commitment to sustainable and natural ingredient sourcing. Operating in a booming sector, Cosmax NBT Inc. impacts industries such as pharmaceuticals, health supplements, and functional foods. The company ensures rigorous quality control and compliance with international standards, positioning itself as a key player in the global wellness and health market. The significance of Cosmax NBT Inc. in the market lies in its role as a trusted supplier for major health product brands worldwide, facilitating innovation and ensuring safety in health supplement formulations. Cosmax NBT Inc.'s dedication to leveraging natural resources makes it a crucial contributor to the shift towards preventive healthcare and wellness.
“Cosmax NBT Inc. trades at a P/E of -9.3 (undervalued) with modest ROE of -29.6%.”
Ask for details →Cosmax NBT Inc. (ticker: 222040) is a company listed on KRX in the Consumer Defensive sector (Packaged Foods). It has approximately 513 employees. Market cap is $140.1B.
The current price is ₩6,790 with a P/E ratio of -9.31x and P/B of 3.17x.
ROE is -29.61% and operating margin is 1.39%. Annual revenue is $287.5B.